Pharming PHAR
NASDAQ PHAR
$9.65 -0.10 (-1.03%)
As of: Oct 21, 2026 · 2:25 PM EDT

Pharming (PHAR) Acquisitions (2025 - 2026)

Updated

Pharming (PHAR) recorded Acquisitions of $6.13 million in Q2 2026, compared with -$57.48 million a year earlier and up 4.5% from the prior quarter.

Analysis

Pharming (PHAR) Acquisitions (2025 - 2026) Analysis & Trends

On a TTM basis, Pharming's Acquisitions came in at -$37.73 million as of Jun 30, 2026; for FY2025, it came in at -$57.48 million.

  • Across earlier years, Acquisitions came in at -$2.53 million in FY2021.
  • Quarterly Acquisitions has ranged from -$57.48 million in Q2 2025 to $7.74 million in Q3 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $5.87 million (Q1 2026), -$57.48 million (Q4 2025) and $7.74 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -17.24 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.21 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Pharming 664.67 Mn -129.70 Mn 141.47 Mn 6.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.13 Mn
Mar 31, 2026 5.87 Mn
Dec 31, 2025 114.95 Mn
Sep 30, 2025 7.74 Mn
Jun 30, 2025 -57.48 Mn
Mar 31, 2025 5.87 Mn
API Access

Pharming Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=PHAR&period=max&api_key=YOUR_API_KEY